Endomag raises £15m in Series D funding led by Draper Esprit to expand cancer care techniques
Draper Esprit led the £15m Series D round to scale product reach and advance breast surgery techniques.
Endomag develops advanced magnetic sensing technology to improve breast cancer care and staging. Its products help clinicians perform more precise, less invasive procedures.
Endomag has secured £15m in Series D funding led by Draper Esprit to expand access to its breast cancer technologies. The capital will also support the company in scaling its product offerings, market reach, and headcount. Sussex Place Ventures participated in the financing alongside other backers.
The company provides magnetic sensing systems, including Sentimag, Magseed, and Magtrace, which assist surgeons in locating tumours and staging breast cancer accurately. These techniques have aided more than 130,000 patients globally by reducing the need for invasive surgeries. This latest investment brings the firm total funding to over £32m.
Use of funds
- 01Grow the team
- 02Continue product development
- 03Expand into international markets
- 04Invest in sales and marketing
